| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |